TrialWorld journal of gastroenterology2024

Nab-paclitaxel plus capecitabine as first-line treatment for advanced biliary tract cancers: An open-label, non-randomized, phase II clinical trial.

Ling-Xiao Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.